food hypersensitivity/fever

BACKGROUND OF THE INVENTION 1. Technical Field The present invention relates to a nitrogen-containing tricyclic compound useful as a medicine, a medicine containing the same and processes for producing the same. More particularly, it relates to a novel nitrogen-containing tricyclic compound useful

BACKGROUND OF THE INVENTION 1. Technical Field The present invention relates to a nitrogen-containing tricyclic compound useful as a medicine, a medicine containing the same and processes for producing the same. More particularly, it relates to a novel nitrogen-containing tricyclic compound useful

BACKGROUND OF THE INVENTION 1. Technical Field The present invention relates to a nitrogen-containing tricyclic compound useful as a medicine, a medicine containing the same and processes for producing the same. More particularly, it relates to a novel nitrogen-containing tricyclic compound useful

FIELD OF THE INVENTION The present invention relates to a heterocyclic ring condensed benzothiazine compound useful as a medicament, a medicament containing the same and processes for producing the same. More specifically, it relates to a novel heterocyclic ring condensed benzothiazine compound

FIELD OF THE INVENTION The present invention relates to the use of cathepsin S inhibitors for the treatment of an allergic condition, in particular an atopic allergic condition. BACKGROUND OF THE INVENTION Atopic allergies afflict at least 20% of populations in developed countries and comprise a

This invention relates to novel diazine-ethenylphenyl oxamic acids and esters and salts thereof, to methods of preparing these compounds, to pharmaceutical compositions containing them as active ingredients, and to methods of using them for the treatment of immunological, inflammatory and allergic

RELATED APPLICATIONS This application claims priority to the Japanese Patent Application No. 2003-421472 dated on Dec. 18, 2003 and is hereby incorporated with reference for all purposes. FIELD OF THE INVENTION The present invention relates to an anti-allergy composition and, in particular, to an

BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to the treatment and prevention of diseases that are primarily due to T cell immune responses. In particular, it relates to the suppression or elimination of certain autoimmune diseases, graft rejection, and allergic